BRPI0813003A2 - Promotor - Google Patents
PromotorInfo
- Publication number
- BRPI0813003A2 BRPI0813003A2 BRPI0813003-5A2A BRPI0813003A BRPI0813003A2 BR PI0813003 A2 BRPI0813003 A2 BR PI0813003A2 BR PI0813003 A BRPI0813003 A BR PI0813003A BR PI0813003 A2 BRPI0813003 A2 BR PI0813003A2
- Authority
- BR
- Brazil
- Prior art keywords
- seq
- promoter
- district attorney
- attorney
- district
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Finger-Pressure Massage (AREA)
- Percussion Or Vibration Massage (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07012772 | 2007-06-29 | ||
| PCT/EP2008/005135 WO2009003622A1 (en) | 2007-06-29 | 2008-06-25 | Promoter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0813003A2 true BRPI0813003A2 (pt) | 2014-10-14 |
Family
ID=38476213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0813003-5A2A BRPI0813003A2 (pt) | 2007-06-29 | 2008-06-25 | Promotor |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9080183B2 (pt) |
| EP (1) | EP2164972B1 (pt) |
| JP (1) | JP5108942B2 (pt) |
| KR (1) | KR101183764B1 (pt) |
| CN (1) | CN101688222B (pt) |
| AT (1) | ATE535607T1 (pt) |
| AU (1) | AU2008271658B8 (pt) |
| BR (1) | BRPI0813003A2 (pt) |
| CA (1) | CA2690475C (pt) |
| ES (1) | ES2377765T3 (pt) |
| IL (1) | IL201818A0 (pt) |
| MX (1) | MX2009013120A (pt) |
| RU (1) | RU2491344C2 (pt) |
| TW (1) | TWI352737B (pt) |
| WO (1) | WO2009003622A1 (pt) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130045471A1 (en) * | 2011-02-25 | 2013-02-21 | Bio-Rad Laboratories, Inc. | Training system for investigations of bioengineered proteins |
| CA2857298A1 (en) * | 2011-11-30 | 2013-06-06 | Abbvie Biotherapeutics Inc. | Vectors and host cells comprising a modified sv40 promoter for protein expression |
| CN107881196A (zh) | 2011-12-22 | 2018-04-06 | 弗·哈夫曼-拉罗切有限公司 | 表达载体组织、新的生产用细胞产生方法及其在重组产生多肽中的用途 |
| SG10201700169PA (en) * | 2011-12-22 | 2017-02-27 | Hoffmann La Roche | Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides |
| US10577627B2 (en) | 2014-06-09 | 2020-03-03 | Voyager Therapeutics, Inc. | Chimeric capsids |
| EP3215191B1 (en) | 2014-11-05 | 2024-08-14 | Voyager Therapeutics, Inc. | Aadc polynucleotides for the treatment of parkinson's disease |
| CN114717264A (zh) | 2014-11-14 | 2022-07-08 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| KR20230145206A (ko) | 2014-11-14 | 2023-10-17 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
| ES2823173T3 (es) | 2016-01-27 | 2021-05-06 | Just Biotherapeutics Inc | Promotor híbrido y usos del mismo |
| US11098310B2 (en) | 2016-01-27 | 2021-08-24 | Just-Evotec Biologics, Inc. | Expression from transposon-based vectors and uses |
| US11261462B2 (en) | 2016-01-27 | 2022-03-01 | Just-Evotec Biologics, Inc. | Inducible expression from transposon-based vectors and uses |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| US10584337B2 (en) | 2016-05-18 | 2020-03-10 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
| IL297576B2 (en) | 2016-05-18 | 2024-02-01 | Voyager Therapeutics Inc | Compositions and methods of treating huntington's disease |
| EP3831281B1 (en) | 2016-08-30 | 2026-02-25 | The Regents of The University of California | Devices and systems for biomedical targeting and delivery |
| MX2019013172A (es) | 2017-05-05 | 2020-09-07 | Voyager Therapeutics Inc | Composiciones y metodos para tratar la enfermedad de huntington. |
| EP3618839A4 (en) | 2017-05-05 | 2021-06-09 | Voyager Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| CA3070087A1 (en) | 2017-07-17 | 2019-01-24 | Voyager Therapeutics, Inc. | Trajectory array guide system |
| US11512327B2 (en) | 2017-08-03 | 2022-11-29 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of AAV |
| MX2020003042A (es) | 2017-09-29 | 2020-11-18 | Voyager Therapeutics Inc | Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa. |
| WO2019079242A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| TW202413649A (zh) | 2017-10-16 | 2024-04-01 | 美商航海家醫療公司 | 肌萎縮性脊髓側索硬化症(als)之治療 |
| CN112424359A (zh) | 2018-05-15 | 2021-02-26 | 沃雅戈治疗公司 | 用于治疗帕金森氏病的组合物和方法 |
| US12281321B2 (en) | 2018-09-28 | 2025-04-22 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4411499A (en) * | 1998-06-05 | 1999-12-20 | Human Genome Sciences, Inc. | Connective tissue growth factor-4 |
| AU2004245175C1 (en) * | 2003-06-10 | 2010-03-18 | Biogen Ma Inc. | Improved secretion of neublastin |
| JP2006050956A (ja) | 2004-08-11 | 2006-02-23 | Japan Science & Technology Agency | プルキンエ細胞における遺伝子の発現のための発現ベクター |
| WO2006117910A1 (ja) * | 2005-04-28 | 2006-11-09 | Mochida Pharmaceutical Co., Ltd. | 抗血小板膜糖蛋白質ⅵモノクローナル抗体 |
-
2008
- 2008-06-25 AU AU2008271658A patent/AU2008271658B8/en active Active
- 2008-06-25 RU RU2010102812/10A patent/RU2491344C2/ru active
- 2008-06-25 ES ES08773642T patent/ES2377765T3/es active Active
- 2008-06-25 JP JP2010513746A patent/JP5108942B2/ja active Active
- 2008-06-25 KR KR1020097027041A patent/KR101183764B1/ko active Active
- 2008-06-25 WO PCT/EP2008/005135 patent/WO2009003622A1/en not_active Ceased
- 2008-06-25 MX MX2009013120A patent/MX2009013120A/es active IP Right Grant
- 2008-06-25 BR BRPI0813003-5A2A patent/BRPI0813003A2/pt not_active Application Discontinuation
- 2008-06-25 EP EP08773642A patent/EP2164972B1/en active Active
- 2008-06-25 CN CN200880022641XA patent/CN101688222B/zh active Active
- 2008-06-25 CA CA2690475A patent/CA2690475C/en active Active
- 2008-06-25 AT AT08773642T patent/ATE535607T1/de active
- 2008-06-25 US US12/664,399 patent/US9080183B2/en active Active
- 2008-06-27 TW TW097124386A patent/TWI352737B/zh active
-
2009
- 2009-10-29 IL IL201818A patent/IL201818A0/en active IP Right Grant
-
2015
- 2015-05-26 US US14/721,061 patent/US9926567B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009003622A1 (en) | 2009-01-08 |
| KR101183764B1 (ko) | 2012-09-17 |
| CN101688222A (zh) | 2010-03-31 |
| CA2690475A1 (en) | 2009-01-08 |
| IL201818A0 (en) | 2011-08-01 |
| WO2009003622A8 (en) | 2009-11-05 |
| US9080183B2 (en) | 2015-07-14 |
| US9926567B2 (en) | 2018-03-27 |
| ES2377765T3 (es) | 2012-03-30 |
| AU2008271658A8 (en) | 2013-07-04 |
| JP5108942B2 (ja) | 2012-12-26 |
| ATE535607T1 (de) | 2011-12-15 |
| JP2010531647A (ja) | 2010-09-30 |
| AU2008271658B2 (en) | 2013-06-06 |
| RU2010102812A (ru) | 2011-08-10 |
| CN101688222B (zh) | 2013-03-06 |
| AU2008271658B8 (en) | 2013-07-04 |
| CA2690475C (en) | 2014-07-29 |
| EP2164972A1 (en) | 2010-03-24 |
| EP2164972B1 (en) | 2011-11-30 |
| US20100159489A1 (en) | 2010-06-24 |
| KR20100024438A (ko) | 2010-03-05 |
| TW200914612A (en) | 2009-04-01 |
| RU2491344C2 (ru) | 2013-08-27 |
| MX2009013120A (es) | 2010-01-15 |
| AU2008271658A1 (en) | 2009-01-08 |
| US20160083735A1 (en) | 2016-03-24 |
| TWI352737B (en) | 2011-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE535607T1 (de) | Promotor | |
| ES2691539T3 (es) | Luciferasas de Oplophorus sintéticas con mayor emisión de luz | |
| IN2012DN05169A (pt) | ||
| MX2015004060A (es) | 3-epimerasa. | |
| ES2676499T3 (es) | Proteínas de fusión Fc que comprenden nuevos enlazadores o disposiciones | |
| BR112014019901A2 (pt) | proteínas de fator viii recombinante | |
| NZ600205A (en) | Selective exosite inhibition of papp-a activity against igfbp-4 | |
| PH12014501602B1 (en) | Chimeric factor viii polypeptides and uses thereof | |
| WO2010129895A3 (en) | Cd133 epitopes | |
| NZ592979A (en) | Bovine viral diarrhea virus with a modified erns protein | |
| EP4328304A3 (en) | Engineered cleavage half-domains | |
| GB201009493D0 (en) | Modified recombinant factor viii and von willebrand factor and methods of use | |
| MX2009007001A (es) | Aminoacidos y polipeptidos fenazina y quinoxalina sustituidos. | |
| EP4345163A3 (en) | Genetic engineering of non-human animals for the production of chimeric antibodies | |
| EA201000327A1 (ru) | Белок | |
| EA201401211A1 (ru) | Улучшенные варианты фермента химозина | |
| UA104933C2 (uk) | ЗЛИТИЙ ПОЛІПЕПТИД ПРОТИ ПУХЛИНИ, ІНДУКОВАНОЇ ВІРУСОМ EB, І МУТАНТ КОЛІЦИНУ Ia | |
| UA108778C2 (xx) | Протираковий злитий протеїн | |
| MX2021006970A (es) | Analogos de insulina que tienen una afinidad de union disminuida al receptor de insulina. | |
| MX2012000133A (es) | Quimera de adn polimerasa del fago phi29. | |
| MX2018008293A (es) | Factor de von willebrand mutado. | |
| WO2008116937A3 (en) | Nucleic acids | |
| CO6382184A2 (es) | Proteinas fijadoras de receptores de interleukinas-21 | |
| MX381723B (es) | Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa. | |
| WO2018069947A8 (en) | Nucleotide sequence expressing an exosome-anchoring protein for use as vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |